000 03988nam a22005295i 4500
001 978-981-97-2859-6
003 DE-He213
005 20250516160133.0
007 cr nn 008mamaa
008 240906s2024 si | s |||| 0|eng d
020 _a9789819728596
_9978-981-97-2859-6
050 4 _aRM300-666
072 7 _aMMG
_2bicssc
072 7 _aMED071000
_2bisacsh
072 7 _aMKG
_2thema
082 0 4 _a615
_223
245 1 0 _aApplication of Nanocarriers in Brain Delivery of Therapeutics
_h[electronic resource] /
_cedited by Amit Alexander.
250 _a1st ed. 2024.
264 1 _aSingapore :
_bSpringer Nature Singapore :
_bImprint: Springer,
_c2024.
300 _aXV, 390 p. 44 illus., 41 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aChapter 1. Introduction to complex brain disorders, currently available therapies, and their limitations -- Chapter 2. Challenges of brain targeting and mechanism of drug transfer across BBB -- Chapter 3. Introduction to nanoparticles as a potential carrier for brain targeting -- Chapter 4. Application of polymeric nanoparticles in brain targeting -- Chapter 5. Recent advancements in lipid nanocarriers for brain delivery of bioactive -- Chapter 6. Liposomes as a potential carrier for brain delivery -- Chapter 7. Inorganic nanoparticles for brain targeting: scope and limitations -- Chapter 8. Potential of dendrimers as a nanocarrier for brain delivery -- Chapter 9. Surface active ligands for enhanced brain targeting of nanoparticles -- Chapter 10. Stimuli-responsive polymers for brain delivery -- Chapter 11. In vitro cell line development and their limitations for brain research -- Chapter 12. In vivo Animal model development and their limitation for brain research -- Chapter 13. Safety, stability concerns, and regulatory aspects of Nanocarriers for brain delivery -- Chapter 14. Current clinical advancements of nanocarriers for brain targeting and limitations in clinical translation.
520 _aThis book presents nanoparticles as potential drug delivery carriers for overcoming the blood-brain barrier. The initial chapter of the book discusses complex brain disorders, the currently available therapies, and their limitations. The book discusses the potential applications of polymeric nanoparticles, lipid nanocarriers, liposomes, inorganic nanoparticles, dendrimers, and stimuli-responsive polymers for targeted brain drug delivery. Further, it evaluates the development and role of different cell lines and animal models in brain research. Towards the end, the book reviews challenges, safety, toxicity, regulatory aspects, future possibilities, and constraints in the clinical translation of nanocarrier systems to treat neurological disorders. The book as such provides valuable information to neuroscientists, and researchers working in pharmaceuticals, nanomedicine, drug delivery research, and nanotechnology.
541 _fUABC ;
_cPerpetuidad
650 0 _aPharmacology.
650 0 _aNeuropharmacology.
650 0 _aNanobiotechnology.
650 1 4 _aPharmacology.
650 2 4 _aNeuropharmacology.
650 2 4 _aNanobiotechnology.
700 1 _aAlexander, Amit.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
773 0 _tSpringer Nature eBook
776 0 8 _iPrinted edition:
_z9789819728589
776 0 8 _iPrinted edition:
_z9789819728602
776 0 8 _iPrinted edition:
_z9789819728619
856 4 0 _zLibro electrónico
_uhttp://libcon.rec.uabc.mx:2048/login?url=https://doi.org/10.1007/978-981-97-2859-6
912 _aZDB-2-SBL
912 _aZDB-2-SXB
942 _cLIBRO_ELEC
999 _c276317
_d276316